Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

524717

TITANBIO

img img img img
No Data Available

TITAN BIOTECH LTD. Share Price Update

As of the latest trading session, TITAN BIOTECH LTD. share price is currently at ₹ 984, which is up by ₹ 18.00 from its previous closing. Today, the stock has fluctuated between ₹ 974.95 and ₹ 1023.00. Over the past year, TITAN BIOTECH LTD. has achieved a return of 27.99 %. In the last month alone, the return has been -6.09 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

TITAN BIOTECH LTD. fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    800.50

  • P/E Ratio (TTM)

    39.82

  • Beta

    0.67

  • Book Value / share

    189.43

  • Return on equity

    13.36%

  • EPS (TTM)

    24.92

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    6.86

info icon alternate text

TITAN BIOTECH LTD. Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2025 (Values in Cr)
Revenue 54.35
Operating Expense 46.46
Net Profit 6.86
Net Profit Margin (%) 12.62
Earnings Per Share (EPS) 8.30
EBITDA 10.65
Effective Tax Rate (%) 25.59
Particulars JUN 2025 (Values in Cr)
Revenue 46.50
Operating Expense 39.11
Net Profit 6.16
Net Profit Margin (%) 13.24
Earnings Per Share (EPS) 7.46
EBITDA 9.45
Effective Tax Rate (%) 24.04
Particulars MAR 2025 (Values in Cr)
Revenue 35.17
Operating Expense 31.52
Net Profit 3.77
Net Profit Margin (%) 10.71
Earnings Per Share (EPS) 4.56
EBITDA 5.95
Effective Tax Rate (%) 25.04
Particulars DEC 2024 (Values in Cr)
Revenue 38.28
Operating Expense 34.76
Net Profit 3.80
Net Profit Margin (%) 9.92
Earnings Per Share (EPS) 4.60
EBITDA 6.43
Effective Tax Rate (%) 25.49
Particulars SEP 2024 (Values in Cr)
Revenue 39.89
Operating Expense 33.50
Net Profit 5.00
Net Profit Margin (%) 12.53
Earnings Per Share (EPS) 6.05
EBITDA 8.09
Effective Tax Rate (%) 25.44
Particulars MAR 2025 (Values in Cr)
Revenue 156.45
Operating Expense 135.99
Net Profit 18.27
Net Profit Margin (%) 11.67
Earnings Per Share (EPS) 22.11
EBITDA 29.34
Effective Tax Rate (%) 25.03
Particulars MAR 2024 (Values in Cr)
Revenue 164.07
Operating Expense 134.29
Net Profit 23.66
Net Profit Margin (%) 14.42
Earnings Per Share (EPS) 28.64
EBITDA 36.03
Effective Tax Rate (%) 24.96
Particulars MAR 2023 (Values in Cr)
Revenue 144.00
Operating Expense 117.83
Net Profit 21.02
Net Profit Margin (%) 14.59
Earnings Per Share (EPS) 25.44
EBITDA 31.47
Effective Tax Rate (%) 25.21
Particulars MAR 2022 (Values in Cr)
Revenue 123.55
Operating Expense 95.52
Net Profit 21.68
Net Profit Margin (%) 17.54
Earnings Per Share (EPS) 26.24
EBITDA 32.21
Effective Tax Rate (%) 25.12
Particulars MAR 2021 (Values in Cr)
Revenue 122.46
Operating Expense 84.04
Net Profit 28.77
Net Profit Margin (%) 23.49
Earnings Per Share (EPS) 34.82
EBITDA 42.14
Effective Tax Rate (%) 25.77
Particulars MAR 2025 (Values in Cr)
Book Value / Share 185.64
ROE % 12.74
ROCE % 16.72
Total Debt to Total Equity 0.04
EBITDA Margin 18.75
Particulars MAR 2024 (Values in Cr)
Book Value / Share 161.49
ROE % 19.44
ROCE % 24.84
Total Debt to Total Equity 0.07
EBITDA Margin 21.96
Particulars MAR 2023 (Values in Cr)
Book Value / Share 133.00
ROE % 21.43
ROCE % 26.64
Total Debt to Total Equity 0.09
EBITDA Margin 21.85
Particulars MAR 2022 (Values in Cr)
Book Value / Share 104.36
ROE % 27.98
ROCE % 32.66
Total Debt to Total Equity 0.16
EBITDA Margin 26.07
Particulars MAR 2021 (Values in Cr)
Book Value / Share 83.21
ROE % 58.75
ROCE % 59.10
Total Debt to Total Equity 0.37
EBITDA Margin 32.80
Particulars MAR 2025 (Values in Cr)
Book Value / Share 175.63
ROE % 13.36
ROCE % 17.49
Total Debt to Total Equity 0.04
EBITDA Margin 18.75
Particulars MAR 2024 (Values in Cr)
Book Value / Share 155.43
ROE % 20.18
ROCE % 25.70
Total Debt to Total Equity 0.07
EBITDA Margin 21.96
Particulars MAR 2023 (Values in Cr)
Book Value / Share 128.38
ROE % 21.86
ROCE % 27.12
Total Debt to Total Equity 0.09
EBITDA Margin 21.85
Particulars MAR 2022 (Values in Cr)
Book Value / Share 104.36
ROE % 28.52
ROCE % 34.30
Total Debt to Total Equity 0.13
EBITDA Margin 26.07
Particulars MAR 2021 (Values in Cr)
Book Value / Share 79.65
ROE % 55.52
ROCE % 59.73
Total Debt to Total Equity 0.27
EBITDA Margin 34.46
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 5.55
Total Assets 174.70
Total Liabilities 174.70
Total Equity 153.40
Share Outstanding 8263700
Price to Book Ratio 2.40
Return on Assets (%) 12.32
Return on Capital (%) 13.85
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 3.28
Total Assets 157.02
Total Liabilities 157.02
Total Equity 133.45
Share Outstanding 8263700
Price to Book Ratio 3.40
Return on Assets (%) 15.82
Return on Capital (%) 17.67
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 4.86
Total Assets 134.51
Total Liabilities 134.51
Total Equity 109.91
Share Outstanding 8263700
Price to Book Ratio 1.53
Return on Assets (%) 18.46
Return on Capital (%) 21.25
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 6.81
Total Assets 108.09
Total Liabilities 108.09
Total Equity 86.24
Share Outstanding 8263700
Price to Book Ratio 2.51
Return on Assets (%) 20.06
Return on Capital (%) 23.12
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 5.45
Total Assets 100.71
Total Liabilities 100.71
Total Equity 72.47
Share Outstanding 8263700
Price to Book Ratio 2.33
Return on Assets (%) 30.11
Return on Capital (%) 35.43
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 5.55
Total Assets 166.43
Total Liabilities 166.43
Total Equity 145.13
Share Outstanding 8263700
Price to Book Ratio 2.40
Return on Assets (%) 10.97
Return on Capital (%) 12.41
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.84
Total Assets 151.57
Total Liabilities 151.57
Total Equity 128.44
Share Outstanding 8263700
Price to Book Ratio 3.40
Return on Assets (%) 15.61
Return on Capital (%) 17.45
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 4.86
Total Assets 130.69
Total Liabilities 130.69
Total Equity 106.09
Share Outstanding 8263700
Price to Book Ratio 1.53
Return on Assets (%) 16.08
Return on Capital (%) 18.59
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 6.81
Total Assets 108.09
Total Liabilities 108.09
Total Equity 86.24
Share Outstanding 8263700
Price to Book Ratio 2.51
Return on Assets (%) 20.06
Return on Capital (%) 23.12
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 5.30
Total Assets 86.17
Total Liabilities 86.17
Total Equity 65.82
Share Outstanding 8263700
Price to Book Ratio 2.33
Return on Assets (%) 33.39
Return on Capital (%) 39.22
Particulars MAR 2025 (Values in Cr)
Net Income 24.36
Cash from Operations 26.11
Cash from Investing -9.87
Cash from Financing -7.96
Net change in Cash 2.28
Free Cash Flow 35.48
Particulars MAR 2024 (Values in Cr)
Net Income 31.52
Cash from Operations 29.01
Cash from Investing -20.30
Cash from Financing -2.86
Net change in Cash -2.02
Free Cash Flow 48.50
Particulars MAR 2023 (Values in Cr)
Net Income 28.11
Cash from Operations 28.67
Cash from Investing -20.72
Cash from Financing -2.40
Net change in Cash -1.95
Free Cash Flow 31.75
Particulars MAR 2022 (Values in Cr)
Net Income 28.96
Cash from Operations 29.15
Cash from Investing -16.43
Cash from Financing -4.09
Net change in Cash 1.50
Free Cash Flow 35.46
Particulars MAR 2021 (Values in Cr)
Net Income 42.70
Cash from Operations 29.96
Cash from Investing -4.86
Cash from Financing -10.59
Net change in Cash 3.61
Free Cash Flow 32.97
Particulars MAR 2025 (Values in Cr)
Net Income 24.36
Cash from Operations 26.11
Cash from Investing -9.87
Cash from Financing -7.96
Net change in Cash 2.28
Free Cash Flow 35.48
Particulars MAR 2024 (Values in Cr)
Net Income 31.52
Cash from Operations 29.01
Cash from Investing -20.30
Cash from Financing -2.86
Net change in Cash -2.02
Free Cash Flow 48.50
Particulars MAR 2023 (Values in Cr)
Net Income 28.11
Cash from Operations 28.67
Cash from Investing -20.72
Cash from Financing -2.40
Net change in Cash -1.95
Free Cash Flow 31.75
Particulars MAR 2022 (Values in Cr)
Net Income 28.96
Cash from Operations 29.15
Cash from Investing -16.43
Cash from Financing -4.09
Net change in Cash 1.50
Free Cash Flow 35.46
Particulars MAR 2021 (Values in Cr)
Net Income 38.76
Cash from Operations 27.74
Cash from Investing -4.17
Cash from Financing -9.80
Net change in Cash 3.60
Free Cash Flow 30.45
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 25.93 12.71 1.34 198.71 25.50 / 53.83
BLISS GVS PHARMA LTD 157.05 15.16 1.46 1661.42 105.05 / 195.85
CIPLA LTD 1377.85 20.46 3.38 111298.76 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 330.80 8.69 2.49 973.58 219.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 25.93 21.08 3.61 198.71 25.50 / 53.83
AMRUTAJAN HEALTH LTD 603.00 30.75 5.09 1743.31 548.05 / 789.95
ASTRAZENECA PHARMA IND LT 8249.70 89.21 25.81 20624.25 6501.60 / 10653.05
BLISS GVS PHARMA LTD 157.05 21.19 1.50 1661.42 105.05 / 195.85

TITAN BIOTECH LTD. shareholding pattern

Holding

44.19%
55.78%
0.02%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

TITAN BIOTECH LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
968.65 -2.37 redarrow
red-green-graph indicator
3 Bearish
13 Bullish
  • 5 Days 1017.50
  • 26 Days 1042.90
  • 10 Days 1031.70
  • 50 Days 1028.10
  • 12 Days 1035.30
  • 100 Days 951.90
  • 20 Days 1042.20
  • 200 Days 828.50
1003.17 PIVOT

First Support

973.33

First Resistance

1022.08

Second Support

954.42

Second Resistance

1051.92

Third Support

924.58

Third Resistance

1070.83

RSI

41.52

ADX

37.06

MACD

-7.61

Williams % R

-92.87

Commodity Channel Index (CCI)

-159.71

Date

2026-01-20

Week

5207.00

Same Day

10958.00

Month

6360.00

1 Year

0.67

3 Year

0.64

Over 1 Month

-6.09%

down

Over 1 Year

27.99%

down

Over 3 Months

-19.91%

down

Over 3 Years

49.64%

down

Over 6 Months

117.67%

down

Over 5 Years

42.46%

down

TITAN BIOTECH LTD. Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
19 Sep 2025 2.0 Final 19 Sep 2025 Equity shares
23 Sep 2024 2.0 Final 24 Sep 2024 Equity shares
22 Sep 2023 1.8 Final 22 Sep 2023 Equity shares
22 Sep 2022 1.5 Final 23 Sep 2022 Equity shares
16 Sep 2021 1.5 Final 08 Sep 2021 Equity shares
17 Sep 2020 1.0 Final 19 Sep 2020 Equity shares
19 Sep 2018 0.75 Final 22 Sep 2018 Equity shares
21 Sep 2017 0.75 Final 23 Sep 2017 Equity shares
22 Sep 2016 0.75 Final 26 Sep 2016 Equity shares
22 Sep 2015 0.75 Final 24 Sep 2015 Equity shares
18 Sep 2014 0.75 Final 22 Sep 2014 Equity shares
19 Sep 2013 0.75 Final 23 Sep 2013 Equity shares
22 Sep 2011 0.75 Final 26 Sep 2011 Equity shares
23 Sep 2010 0.5 Final 25 Sep 2010 Equity shares

Top Gainers

TITAN BIOTECH LTD. Share Price

Titan Biotech Limited, the New Delhi based company is into manufacture of Biological Peptones, Extracts and Dehydrated Culture media which are very conducive for the growth of micro organisms. They are primarily used in the development and growth of micro organisms in clinical diagnosis production of vaccines antibiotics antisera etc, Checking the sensitivity of antibiotics in pharmaceutical industry, checking the bacterial contamination in food & water, tissue culture laboratories and in the departments of microbiology & botony in medical colleges/universities.

The company uses Meat, Bile, Pancreatic, Liver, Blood, Brain, Heart and other parts of animals sourced from slaughter house and other vegetable products like soya, casein etc. converting them into free flowing powder to produce Peptones, Extracts and Hydrolysates which are further used in manufacturing of Dehydrated Culture Media and as raw material in pharma health products and other industries.

During 2006-07, Company introduced new culture media with gama radiation including readymade sterile media and dehydrated sterile media. Besides, it also introduced lab chemicals and agaroses to serve microbiology research institutes and in various applications of microbiology like food, aquatic, veretinary, cosmetics, pharma, heaith care, medical environment. It developed Amino acid Chelates and harmonized media in 2009-10.

The Company has already started modernization of its existing plant, Building at Bhiwadi, Rajasthan for meeting international standards and quality improvement. With improvement in Building and Modernisation of Existing Plant, Company will be able to cater the needs of its customers in a better way and provide high quality products meeting international standards to its domestic as well as overseas customers.

Parent organization Indian Private
NSE symbol [-]
Founded 1992
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Titan Biotech Ltd?

Answer Field

Titan Biotech Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 968.65 as on Jan 22 2026 11:02 AM.

What is the Market Cap of Titan Biotech Ltd Share?

Answer Field

The market cap of Titan Biotech Ltd for NSE ₹ 0.00 & for BSE ₹ 800.50 as on Jan 22 2026 11:02 AM.

What is the 52 Week High and Low of Titan Biotech Ltd?

Answer Field

The 52 Week High and Low of Titan Biotech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 1,419.00 and ₹ 373.65.

What is 1 year return for Titan Biotech Ltd?

Answer Field

The 1 year returns on the stock has been 27.99%.

What is the P/E Ratio of Titan Biotech Ltd Share?

Answer Field

As on Jan 22 2026 11:02 AM the price-to-earnings (PE) ratio for Titan Biotech Ltd share is 39.82.

What is the PB ratio of Titan Biotech Ltd Share?

Answer Field

As on Jan 22 2026 11:02 AM, the price-to-book (PB) ratio for Titan Biotech Ltd share is 189.43.

How to Buy Titan Biotech Ltd Share?

Answer Field

You can trade in Titan Biotech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Titan Biotech Ltd Share on Bajaj Broking App?

Answer Field

To buy Titan Biotech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Titan Biotech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59